Cadila gets USFDA approval to market drug for prostate condition
Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules. It is used to treat symptoms of Benign...
Tag : Cadila
Cadila partners with Medicure to launch cholesterol drug
Cadila Healthcare has entered into partnership with Medicure to launch cholesterol drug in the US market. The company has entered into a definitive agreement with...
Cadila receives USFDA approval for marketing hypertension drug
Zydus Pharmaceuticals (USA) Inc, a wholly owned subsidiary of Cadila Healthcare, has got final approval from the US Food and Drug Administration to market Nifedipine extended...
Cadila receives USFDA approval for drug that treats schizophrenia
Cadila Healthcare’s subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Cadila gets USFDA approval for blood pressure treatment drug
Zydus Cadila has received final approval to market Candesartan Cilexetil and Hydrochlorothiazide tablets formulations, from the US health regulator. It is used for treating high blood...
Cadila receives USFDA approval for acne drug
Zydus Cadila has received final approval to market minocycline hydrochloride extended release tablets, which is used for treating acne, from the US health regulator. The drug...
Cadila receives USFDA approval, to sell erectile dysfunction drug
Zydus Cadila has received approval to market Tadalafil tablets in the US market, from the US health regulator. It is used for treatment of erectile dysfunction and...
Cadila has signed an agreement with Supernus Pharma to settle patent issue
Cadila Healthcare has signed an agreement with Supernus Pharmaceuticals for settling a patent litigation regarding Trokendi XR extended release capsules that are used in treatment...
Cadila receives 3 observations from USFDA for its Baddi formulation plant
Cadila Healthcare said that it has received three observations from USFDA for its formulation facility at Baddi, Himachal Pradesh. From February 20 to March 1,...
Cadila buys 50% stake of Zydus BSV Pharma
On Thursday Cadila Healthcare acquired 50 per cent stake from Bharat Serum and Vaccines in its JV firm. “The company has purchased 50 percent shares...